Relmada Therapeutics Appoints CNS Specialist Thomas C. Wessel, M.D., Ph.D., as executive Vice President, Head of Research and Development
News
Palvella Therapeutics Completes Enrollment in Phase 2/3 Pivotal Study of PTX-022 for Treatment of Pachyonychia Congenita
Top-Line Data Expected in Q4 2020 for Fast Track-Designated Program
Ride Health CEO Imran Cronk to Present at South by Southwest Alongside Leaders from American Heart Association and Ascension
Company also exhibiting cloud-based transportation coordination platform at RISE Medicare Advantage Summit and AMGA Annual Conference
Pillo Health Introduces Groundbreaking Automation of Multi-Dose Prescription Packaging
All-in-one pill packaging automation software streamlines pharmacies’ ability to fill multi-dose prescriptions that integrate into Pillo’s home health robot.
Pillo Health Launches Pillo Remotely, a Population Health Data and Device Manager to Improve Engagement & Visibility into In-Home Health Habits
Customizable device management interface offers increased control for healthcare professionals to deliver relevant, engaging communication to patients at scale.
This isn’t a ‘biotech bubble,’ it’s ‘Philadelphia’s moment’ to become a center for gene therapy, says Penn-based CEO
Anne Prener, M.D., Ph.D. Appointed to Renovacor Board of Directors and Scientific Advisory Board
Former CEO of Freeline Therapeutics, Ltd. has outstanding international drug development, commercialization expertise, with focus on rare disease, gene therapy
Annovis Issued Patent for Method of Treating Parkinson’s Disease and Other Lewy Body Diseases
Curb and Ride Health Give Hospitals and Health Plans a Better Way to Hail Taxis for Patients